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In contrast to classical transmitters, the detailed structures and cellular and synaptic actions of neuropeptides are less well described.
Peptide mass profiling of single identified neurons of the mollusc Lymnaea stagnalis indicated the presence of 17 abundant neuropep-
tides in the cardiorespiratory neuron, visceral dorsal 1 (VD1), and a subset of 14 peptides in its electrically coupled counterpart, right
parietal dorsal 2.Altogether, basedon this andpreviouswork,we showed that thehighnumberof peptides arises fromthe expressionand
processing of four distinct peptide precursor proteins, including a novel one. Second, we established a variety of posttranslational
modifications of the generated peptides, including phosphorylation, disulphide linkage, glycosylation, hydroxylation, N-terminal pyro-
glutamylation, and C-terminal amidation. Specific synapses between VD1 and its muscle targets were formed, and their synaptic physi-
ologywas investigated.Whole-cell voltage-clamp analysis of dissociated heartmuscle cells revealed, as tested for a selection of represen-
tative family members and their modifications, that the peptides of VD1 exhibit convergent activation of a high-voltage-activated Ca
current. Moreover, the differentially glycosylated and hydroxylated 2 peptides were more potent than the unmodified 2 peptide in
enhancing these currents. Together, this study is the first to demonstrate that single neurons exhibit such a complex pattern of peptide
gene expression, precursor processing, and differential peptide modifications along with a remarkable degree of convergence of neuro-
modulatory actions. This study thus underscores the importance of a detailed mass spectrometric analysis of neuronal peptide content
and peptide modifications related to neuromodulatory function.
Key words: mollusk; MALDI-TOF mass spectrometry; glycopeptide; posttranslational modification; HVA calcium channel;
neuromodulation
Introduction
Neuropeptides play many important roles in the generation of
behavior and the regulation of physiological processes in both
vertebrates and invertebrates. Often, multiple neuropeptides are
coexpressed in single cells, and their combinatorial action
through divergent as well as convergent pathways enhance the
information processing capacity of neurons in the nervous sys-
tem (Kupfermann, 1991; Peaker, 1992; Zupanc, 1996; Brezina
and Weiss, 1997; Hokfelt et al., 2000; Kupfermann and Weiss,
2001; Nusbaum et al., 2001; Merighi, 2002). This emphasizes the
importance of detailed knowledge of the full complement of the
chemical diversity of the coexpressed neuropeptides in relation to
their possible action as cotransmitters in neuronal
communication.
In principle, peptide diversity can be generated via several
mechanisms, namely (1) cell-specific coexpression of distinct
peptide precursor genes (Cropper et al., 1987; Church and Lloyd,
1991; Hekimi et al., 1991; Vilim et al., 1996; Jimenez et al., 1998;
Wood et al., 2000), (2) alternative splicing of a pre-mRNAencod-
ing different precursors (Saunders et al., 1992; Bogerd et al.,
1993), (3) alternative proteolytic processing of a precursor pro-
tein (Eipper and Mains, 1980) and (4) posttranslational modifi-
cations of the peptides (Loh, 1992; Dockray et al., 1996). In all
instances, a peptidomics approach based on mass spectrometry
has proven to be superior to other classic biochemical approaches
for defining peptide diversity at the level of single cells and small
biopsies (Jimenez and Burlingame, 1998; Li et al., 2000; Schrader
and Schulz-Knappe, 2001). Although studies using this method-
ology have revealed that the coexistence of multiple neuropep-
tides in single (invertebrate) neurons is a general phenomenon,
the physiological significance of the full chemical diversity of
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peptides, including that generated by posttranslational modifica-
tions, has not been determined.
The identifiable neuron visceral dorsal 1 (VD1) and the elec-
trically coupled right parietal dorsal 2 (RPD2) in the brain of the
mollusc Lymnaea stagnalis provide a convenient model prepara-
tion in which to examine the generation of peptide diversity in
the context of biological function, namely, the modulation of
cardiorespiratory behavior (Janse et al., 1985; Kerkhoven et al.,
1991). Previous studies have identified three peptides in VD1 and
RPD2, of which two were shown to possess cardioexcitatory ef-
fects (Bogerd et al., 1994). Subsequent mass spectrometric anal-
ysis of single VD1 and RPD2 neurons (Jimenez et al., 1994, 1998)
revealed overlapping peptide profiles and the presence of a total
of 17 abundant mass peaks, representing putative peptides. This
finding suggested that the peptide phenotype ofVD1 andRPD2 is
far more complex than reported previously (Bogerd et al., 1994)
because of the expression of hitherto unknown neuropeptides
and/or posttranslational processing.
To begin understanding the significance of neuropeptide di-
versity in VD1 and RPD2 and its functional correlate on target
cells, we first performed a peptidomics approach to characterize
the unidentified neuropeptides present in VD1 and RPD2, in-
cluding their posttranslational modifications. Subsequent func-
tional analysis of VD1 and RPD2 peptides on its target cells, i.e.,
heart muscle cells, showed that peptides derived from distinct
precursor proteins and differentiallymodified forms exhibit con-
vergent yet differential activation of the same calcium channel
current in heart muscle fibers.
Materials andMethods
Animals
Adult specimens of L. stagnalis (shell height, 30–35 mm) bred in the
laboratory under standard conditions were used. The animals were kept
at 20°C and a 12 h light/dark cycle and were fed lettuce ad libitum.
Extraction and purification of peptides
Dissected VD1 and RPD2, which shares the same set of peptides as VD1
with the exception of the small cardioactive peptides (SCPs) (Jimenez et
al., 1998), were collected on solid carbon dioxide and stored at 20°C.
Pooled neurons (total, 800) were extracted by boiling in 0.1 M acetic acid
for 8 min and centrifuged for 10 min at 4°C, and the supernatant was
fractionated by HPLC using a Nucleosil C18 column (5 m; 250  2.1
mm) with an increasing concentration of acetonitrile in 7 mM trifluoro-
acetic acid (TFA). The flow ratewas 300l/min, and 1min fractionswere
collected. Each fractionwas screened bymatrix-assisted laser desorption/
ionization time-of-flight mass spectrometry (MALDI-TOF-MS) to
search for the molecular ion species that were detected in the single VD1
mass spectrum. In some cases, fractions that contained the molecules of
interest were further separated using the same Nucleosil column with
increasing acetonitrile concentration in 0.05% HCl.
Mass spectrometry
ForMALDI-TOF-MS, an aliquot (0.5l) of each sample (HPLC fraction
or enzymatic digest) was mixed with 1 l of matrix (10 mg 2,5-
dihydroxy-benzoic acid and 1mg 5-methoxy-2-benzoic acid dissolved in
1 ml of 7.5 mM trifluoroacetic acid in 30% acetonitrile). After drying of
the sample, the target was placed into a laboratory-built laser desorption
reflectron time-of-flight mass spectrometer equipped with a pulsed ni-
trogen laser (337 nm; pulse width, 3 ns) for analysis, as described previ-
ously (Jimenez et al., 1998). The spectra were externally calibrated using
a peptide mixture, yielding an accuracy of 0.05%.
To obtain peptide sequence information, post-source decay mass
spectra were recorded on a VGTofspec SE time-of-flightmass spectrom-
eter (Micromass, Manchester, UK) equipped with a nitrogen laser oper-
ated in reflectron mode, as described previously (Matsui et al., 1997).
Samples were prepared as described above.
Electrospray MS and fragmentation spectra were recorded using a
triple–quadrupole instrument (API300) from MDS-Sciex (Concord,
Ontario, Canada) with a standard ion spray source that was infused at 5
l/min. The collisionally induced dissociation gas usedwas nitrogen, and
the collision energy was 35–50 eV, 0.2 Da step size, and 5–10 s total scan
time.
Amino acid sequence analysis
Amino acid sequencing was performed by automated Edman degrada-
tion in a model 473 pulse liquid phase sequencer (Applied Biosystems,
Foster City, CA), using the sequencing program recommended by the
company. The sequence data were also used for quantification of the
amount of peptides purified.
Enzymatic digestions
Purified peptide I was incubated with 1 g of endo-lys-c (Sigma, St.
Louis, MO) in 100 l of 50 mM ammonium acetate buffer containing 1
mM dithiothreitol for 18 h at 20°C. Purified peptide K and 2 peptides
were incubatedwith 1g of trypsin (Promega,Madison,WI) in 100l of
50mMammoniumcarbonate buffer for 18 h at 20°C.Dephosphorylation
of peptide K was performed by incubation with calf intestine alkaline
phosphatase (Promega) in 100l of 50mM ammonium carbonate buffer
containing 1 mMmagnesium chloride for 30 min at 30°C. Digested pep-
tides were directly analyzed by MALDI-TOF-MS and in some cases pu-
rified by reversed-phase HPLC using trifluoroacetic acid as counterion.
Cloning and sequencing of pro-I cDNA, Northern blotting, and in
situ hybridization
To obtain the cDNA sequence of the precursor of peptide I (pro-I) first
two degenerate nested antisense primers oligo VD cells (OLVD2) [5-
GGAATTCGGIACNGGNAC(GA)AA(TC)TCNC(TG)(GA)TC-3] and
OLVD3 [5-GGAATTCGIAC(GA)AA(TC)TCNC(TG)(GA)TC(TC)-
TC(GA)TANGC-3] (Isogen Bioscience, Ijsselstein, The Netherlands)
containing 5-EcoRI restriction sites, designed on the partial peptide I
sequence KAYEDREFVPVVPK were used. Then, two specific nested
sense primers, I-peptide query sense (IQS3) (5-GGGAGCTCA-
GTTATATCCAGACTGCAG-3) and IQS4 (5-GGGATCCAGAC-
TGCAGAACGGAG-3) (Isogen Bioscience) containing 5-BamHI
restriction sites, designed on the 5 end of the obtained 5 rapid amplifi-
cation of cDNA ends (RACE) I-clone, were used. The specific peptide I
primers were used in combination with an anchored dT primer [adaptor
oligo A (ADA)-(dT20)] and its respective adaptor primers ADA-I and
ADA-II (Tensen et al., 1994) in 5 RACE and 3 RACE PCR on hex-
anucleotide primed cDNA from single RPD2 neurons as described pre-
viously (Spijker et al., 1999) with the following modifications. Three
individual RPD2s were isolated using a fine glass pipette (tip diameter,
100 m) and transferred to a glass plate. After removal of superfluous
liquid, 11l of water containing 400 pmol of hexanucleotides was added
andmixed, and the samplewas heated andprocessed for cDNA synthesis.
After incubation, the cDNA was phenolized and precipitated. After
dATP tailing, each cDNA synthesis was used for a first, a second, and a
third round of amplification using 50 pmol of I-primer (OLVD2 or
IQS3) in combination with ADA-(dT20), 50 pmol of I-primer (OLVD2
or IQS3) in combination with 50 pmol of ADA-I, and 50 pmol of nested
I-primer (OLVD3or IQS4) in combinationwith 50 pmol of nested adap-
tor primer ADA-II. Amplified cDNA of 5 and 3 RACE was digested
with EcoRI/SacI or with BamHI/SacI and separated on an agarose gel.
Fragments were cloned and sequenced in both orientations according to
the dideoxy chain termination method (Sanger et al., 1977), using T7
DNA polymerase.
Total RNA fromvisceral and parietal ganglia was isolated (Chomczyn-
ski and Sacchi, 1987), and10 g of RNA was glyoxylated, fractionated
on a 1.8% agarose gel, and transferred to charged nylon membranes. A
peptide-I-specific 3 RACE clone (nucleotides 79–633) was used to
make a randomly primed probe, labeled with [- 32P]dATP (specific
activity109 cpm/g) by primer extension. Themembrane was hybrid-
ized in 6 SSC, 0.2% SDS, 5Denhardt’s solution, 10g/ml tRNA, and
10 g/ml herring sperm DNA, at 65°C for 16 h, subsequently washed in
0.5 SSC and 0.2% SDS at 65°C for 45min, and then autoradiographed.
The cellular localization of mRNA encoding peptide I was studied in
sections of the visceral and right parietal ganglia of L. stagnalis by in situ
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hybridization using a digoxigenin–dUTP-
labeled cRNA. Parallel sections were used to
confirm the simultaneous presence of 1 pep-
tide in VD1 and RPD2 using immunocyto-
chemistry. Tissue was fixed in 1% paraformal-
dehyde and 1% acetic acid (Smit et al., 1996).
cRNAprobes were synthesized from100 ng of a
PCR fragment of the M13 vector containing a
partial I-peptide cDNA (nucleotides 1–260), in-
cluding the T3 and T7 RNA polymerase promo-
tor. Hybridization, washing, and visualization
were done as described by Smit et al. (1996).
Cardiac muscle dissociation and
neuron isolation
Muscle cells were dissociated from dissected
atria and ventricles under sterile conditions us-
ing 0.2% dispase/collagenase in defined me-
dium (Ridgway et al., 1991) (one auricle or ven-
tricle per ml) for 4 h at 30°C while gently
shaking. The dissociated cells were subse-
quently washed three times with defined me-
dium and sedimented at low speed, before plat-
ing. Dissociated muscle fibers were kept in
defined medium in Costar (Cambridge, MA)
dishes at 20°C for 1–4 d (Lee et al., 2002). All
neuronal culture procedures were performed
as described previously (Syed et al., 1990). In
brief, VD1 and right pedal dorsal 1 (RPeD1)
were mechanically isolated under sterile condi-
tions from the brain by applying gentle suction
through a fire-polished pipette. Isolated cells
were plated directly on poly-L-lysine-coated
dishes containing brain-conditioned medium.
After 24 h in culture, muscle cells were plated
on top of neurites of VD1, and synapses were
allowed to form during 24 h.
Electrophysiology
Simultaneous intracellular recordings from
cocultured cells. For intracellular recordings,
conventional electrophysiological techniques
were used as described previously (Syed et al.,
1990). Glassmicroelectrodes (resistance of 20–40M) were filled with a
saturated solution of potassium sulfate (K2SO4), and neurons were im-
paled usingNarishige (Tokyo, Japan)micromanipulators (modelsM202
and M204). The electrophysiological signals were amplified (amplifier
model IR-283; Neurodata Instruments, New York, NY), displayed on a
digital storage oscilloscope (Philips PM 3394), and recorded on a Gould
Instruments (Valley View, OH) chart recorder (model TA240S).
Voltage-clamp recordings. Dissociated ventricle and auricle cells were
bathed in HEPES-buffered saline (HBS) (see above). To record calcium
currents, we used Ba2 as charge carrier. HBS was washed out and re-
placed under continuous perfusion by a solution containing the follow-
ing (inmM): 40NaCl, 2 BaCl2, 10HEPES, and 2 4-aminopyridine, pH 7.8
adjusted with tetraethylammonium (TEA)-OH. The internal pipette so-
lution contained the following (inmM): 5 TEA-Cl, 29 CsCl, 2.3 CaCl2, 10
HEPES, 11 EGTA, 2 ATP-Mg, and 0.1 GTP-Tris, pH 7.4 adjusted with
CsOH. The calculated free calcium concentration was 108 M. Peptides
were administered by micropressure ejection or Y-tube application. The
Y-tube system used a pipette that was held under negative pressure and
continuously perfused with a solution containing the relevant peptide.
The tip of this pipette (diameter of 20 m) was placed near the re-
corded cell. By switching on an electrically operated valve, the negative
pressure was interrupted and a gentle flow of peptide solution, driven by
gravity, was perfused over the cell. In this way, peptide application was
accomplished within 500 ms. Whole-cell voltage-clamp experiments
were performed with a List Electronics (Darmstadt, Germany) EPC 7 or
an Axopatch 2B amplifier (Axon Instruments, Union City, CA), using a
0.1 G feedback resistance. Pipettes (2–6 M) were pulled on a Flam-
ing/Brown P-87 (Sutter Instruments, Novato, CA) horizontalmicroelec-
trode puller fromClarke Electromedical Instruments (Pangbourne, UK)
GC-150 glass. In the cell-attached configuration (seal resistance of 1
G or more), the fast capacitive transients of the patch pipette were
compensated. After disruption of the patch membrane, series resistance
(7 M) and cell capacitance (100 pF) were compensated. In the
whole-cell mode, wewaited15min beforemeasuring barium currents,
to equilibrate the interior of the cell with the pipette solution. Data ac-
quisition was controlled by a CED 1401 analog-to-digital converter
(Cambridge Electronics Design, Cambridge, UK) connected to an Intel
80486-based computer, run with voltage-clamp software developed in
our laboratory. The current recordings were filtered at 1–5 kHz, sampled
at2 kHz, and stored on-line. This system allowed simultaneous appli-
cation of voltage steps, acquisition of current recordings, and timed ap-
plication of peptides.
Data analysis. The data points of the dose–response curve were fitted
by a four-parameter Hill function (r 	 0.9908) using Sigma Plot 2000
software (SPSS, Chicago, IL). A one-way ANOVA in conjunction with a
post hoc Tukey–Kramer test was used to assess the significance of dose
dependence. A Student’s t test was used ( p
 0.05) for comparison of the
effect of the differentially modified 2 peptides.
Results
Purification and characterization of VD1 peptides
Profiling of single VD1 and RPD2 neurons by MALDI-TOF-MS
revealed a multitude of major molecular ions that are named
Figure 1. MALDI mass spectra of a single VD1 neuron. The mass spectrum of VD1 (A) and an x-axis expansion displaying the
mass range of m/z of 2000–4200 (B) show the presence of multiple molecular ions labeled A–L. Molecular ions D2–H2 occur at
a 16 Da mass increment from D–H, respectively. Molecular ions D, E, and J correspond to peptides encoded by the  peptide
precursors (Bogerd et al., 1994) and molecular ions A, B, and L to peptides derived from the SCP precursor (Jimenez et al., 1998).
Molecular ions C, D2, E2, F and F2, G and G2, H and H2, I, and K represent hitherto unidentified putative peptides. x-Axis,
mass-to-charge ratio; y-axis, ion intensity in arbitrary units.
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molecules A–L (Fig. 1A) (Jimenez et al., 1998). Closer examina-
tion of the mass region containing molecules D–H (Fig. 1B) re-
vealed that mass peaks D–H are each accompanied by an extra
peak at a mass increment of 16 Da, which are named accordingly
as molecules D2, E2, F2, G2, and H2 (Fig. 1B). Previous studies
have identified someof theVD1 andRPD2molecules as bioactive
peptides; peptides A, B, and L are uniquely expressed in VD1 and
represent the small cardioactive peptides A, B, and the
C-terminal peptide, respectively, that are all derived from the
small cardioactive peptide precursor (Jimenez et al., 1998). Pep-
tides D, E, and J correspond to the1,2, and peptides, respec-
tively, derived from the alternatively spliced 1 and 2 precur-
sors expressed in both VD1 and RPD2 (Bogerd et al., 1994), with
the  peptide contained in both precursors. The remaining mass
peaks, i.e., molecules C, D2, E2, F, F2, G, G2, H, H2, I, and K, are
present in both VD1 and RPD2 (Jimenez et al., 1998) and do not
correspond to previously characterized peptides, suggesting that
they may represent novel and/or posttranslationally modified
peptides. Moreover, these peptides are present in all single-cell
VD1 spectra analyzed to date (up to a few hundred), indicating
the robustness of their expression. To gain additional insight into
these molecules, we purified them from 800 individually dis-
sected VD1 and RPD2, using a C18 column with increasing ace-
tonitrile concentration in TFA (Fig. 2). Screening of each HPLC
fraction with MALDI-TOF-MS allowed us to localize the frac-
tions with the molecules of interest (Figs. 1, 2), which were then
subjected to additional purification using reversed-phase HPLC
(if necessary), structural characterization, and functional studies.
Table 1 contains a summary of the mass spectrometry and se-
quencing data of the peptides identified in this study.
MALDI-TOF-MS screening of the HPLC fractions revealed
that molecule C [mass-to-charge ratio (m/z) of 1160.1] (Table 1)
eluted in fraction 23, and the structure was established by Edman
degradation as DRRLNGDTVN. This peptide corresponds to
residues 38–47 of the N-terminal of the  peptide prohormones
(Bogerd et al., 1993). Peptide material in fractions eluting at 42,
43, 45, 48, 51, 53, 54, and 55 min (Fig. 2) contained molecular
ions corresponding to molecules H2 (m/z of 4149.5), H (m/z of
4133.6), G2 (m/z of 3770.8), G (m/z of 3754.8), F2 (m/z of
3391.8), F (m/z of 3375.7), D2 (m/z of 2417.0), and E2 (m/z
of 3012.7), respectively, as those detected in the single-cell mass
spectrum of VD1 (Fig. 1, Table 1). Some of these peptides were
further resolved using reversed-phase HPLCwith HCl as a coun-
terion (data not shown). Molecule D2, which occurs at a mass
increment of 16Da to1 peptide, yielded an1 peptide sequence
(DMYEGLAGRCQHHPRNCPGFN), indicating a modification
(see below). Molecules F, G, and H are 379 Da (molecule F), two
times 379 Da (molecule G), and three times 379 Da (molecule H)
heavier than 2 peptide, suggesting that they represent multiple
posttranslationally modified forms of this peptide. Indeed, Ed-
man sequencing of purified molecules F, G, and H all yielded the
same amino acid sequence, namely that of the 2 peptide (DM-
VTTTRIGTGGLAGRCQHHPRNCPGFN). In addition, F2, G2,
and H2, which differ each by 16 Da to F, G, and H, respectively,
also yielded an 2 peptide sequence.
To locate the site(s) of the posttranslational modification(s),
10% of the purified peptides F, G, and H and their 16 Da
variants were pooled together and digested with trypsin. The re-
mainder was kept for bioassay experiments. For comparison,
synthetic 2 peptide was also digested with trypsin (Fig. 3A). As
expected, trypsin cleavage of synthetic 2 peptide yields three
Table 1. Summary of themolecular weight, sequence, and peptidemapping data obtained for the novel VD1 peptides of the Lymnaea brain (compare with Fig. 1)
Mass peak Measured MH VD1 Measured MH HPLC Peptide name Calculated unmodified MH Mass difference (Da) Modification
C 1160.0 1160.1 DRRLNGDTVN 1159.9 0
D2 2418.1a 2417.0a 1 24001.7 16 Hydroxylation
E2 3013.2a 3012.7a 2 2996.4 16 Hydroxylation
F 3375.8a 3375.7a 2 2996.4 1 379 Monoglycosylation
F2 3392.4a 3391.8a 2 2996.4 395 Monoglycosylation and hydroxylation
G 3755.0a 3754.8a 2 2996.4 759 (2 379) Diglycosylation
G2 3771.4a 3770.8a a2 2996.4 775 Diglycosylation and hydroxylation
H 4134.8a 4133.6a 2 2996.4 1138 (3 379) Triglycosylation
H2 4151.3a 4149.5a 2 2996.4 1154 Triglycosylation and hydroxylation
I 6020.2 6019.1 LyCCAP 6027.1 6 3 disulphide bridge
K 6455.4 6457.0 B 6375.9 80 Phosphorylation
Themolecular weight of each calculated andmeasured protonatedmolecular ion (MH) is listed, as well as the approximatemass difference from the calculated unmodifiedmass. Themass accuracy was 0.01–0.05%. The peptide names
were assigned based on Edman degradation data. Monoglycosylation, diglycosylation, and triglycosylation indicates modification of one, two, or three Thr residues, respectively, in the N terminus of the 2 peptide with the 379 Da
glycomoiety (HexNAc–hexuronic acid). For details of the amino acid sequence andmodifications of2 and peptides, see Figures 3 and 4, respectively. For the cDNA precursor and deduced amino acid sequence of peptide I/LyCCAP, see
Figure 5. Peptides A, B, D, E, J, and L are not listed because they correspond to the previously identified SCP precursor peptides (Jimenez et al., 1998) and unmodified1,2, and peptide (Bogerd et al., 1994).
aAll peptides (D2, E2, F, F2, G, G2, H, and H2) also contain a disulphide bridge.
Figure 2. Purification of peptides from neurons VD1 and RPD2 using reverse-phase HPLC.
Peptides were extracted from 800 VD1 and RPD2 neurons and resolved on a C18 column using
anacetonitrile gradient in 7.5mMTFAas a counter ion. Fractions eluting at 23, 42, 43, 45, 48, 51,
53, 54, 55, 67, and 113min containedmoleculeswithmasses that corresponded tomolecules C,
H2, H, G2, G, F2, F, D2, E2, I, and K, respectively, of the VD1mass spectra in Figure 1. The elution
positions of peptides F, G, and H as well as those of the previously identified 1, 2, and 
peptides (Bogerd et al., 1994) and SCPs (Jimenez et al., 1998) are indicated. In some cases, to
obtain pure peptide, it was necessary to further resolve peptides on a second gradient usingHCl
as a counter ion. The dashed line indicates the gradient of acetonitrile.
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specific peptides (at m/z of 802.1, 825.1, and 1426.3) that cover
the full peptide sequence (Fig. 3A, right, B). The molecular ion at
m/z of 1426.3 represents tryptic peptides 3 and 4, which are still
connected via a disulphide bridge. After trypsin cleavage of the
pool of modified 2 peptides F, F2, G, G2, H, and H2, three
specific peptides were detected, namely those corresponding to
tryptic peptides 2, disulphide-linked peptides 3  4, and
disulphide-linked peptides 3 4(16 Da) (see below) (Fig. 3A,
left). Tryptic peptide 1 (m/z of 825.1) was absent from the spec-
trum, suggesting that the site of the 379 Da modification resides
in the N-terminal part of the 2 peptide. However, the expected
posttranslationally modified tryptic peptide 1 was not detected at
mass increments of 379 Da of the native peptide. Therefore, un-
der the present MS conditions, the structure of modified tryptic
peptide 1 may be unfavorable for the desorption/ionization pro-
cess and so cannot be effectively detected and further analyzed.
Alternatively, to obtain structural information on the 379 Da
modification, we subjected the intact variant 2 peptides to low-
energy collisions on a triple–quadrupole instrument. Figure 3C
shows the MS/MS spectrum of peptide F2. The low-mass region
contains numerous carbohydrate-related fragments, indicating
Figure 4. Phosphatase treatment and tryptic peptide mapping of purified peptide K dem-
onstrates phosphorylation of the C terminal of thepeptide.A,MALDImass analysis of peptide
K before (left) and after (right) dephosphorylation) using calf-intestine alkaline phosphatase
(CIAP) shows removal of the 80 Da, phosphate moiety. B, Primary sequence of the peptide.
Trypsin cleaves after basic residues (indicated by the arrows), yielding five digest fragments,
containing residues 1–9, 10–19, 20–35, 36–43, and 44–57, in case of a complete digestion.
The putative phosphorylation sites are indicated with an asterisk. C, MALDI mass analysis of a
tryptic digest of the phosphorylated  peptide (purified peptide K). Numbers indicate the
residues of the trypsin fragments. Note the 80 Da mass addition to the partially cleaved
C-terminal fragment 36–57. Unidentified molecular ions are labeled with a question mark.
Figure 3. Structural characterization of themodified2 peptides revealsmultiple differen-
tially glycosylated forms of the 2 peptide that in addition contains a HyP residue. A, MALDI
mass spectra of a tryptic digest of the pooledmodified2 peptides F, F2, G, G2, H, and H2 (left)
and synthetic2 peptide (right). The arrow in A indicates the location of2 tryptic peptide 1
that is expected to bemodified (seeB) and that has disappeared in the spectrumof the digested
modified 2 peptides. Numbers indicate expected 2-specific tryptic peptides. Tr, Auto-
proteolytic fragments of trypsin. A, A-specific ion. B, Primary sequence of the 2 peptide.
Trypsin cleaves after basic residues (indicated by the arrows), yielding four tryptic peptides.
Fragments 3 and 4 are held together by a disulphide bridge. The sites predicted to be glycosy-
lated are indicated by an asterisk. C, Electrospray MS/MS spectrum (the lower mass range) of
purified2 variant peptide F reveals glycosylation of F. Note the abundance of HexNac (at m/z
of 204) and HexNac-related ions (m/z of 186, 168, 144, and 126). D, Identification of the 16 Da
moiety on themodified2peptides ashydroxy-proline. Post-sourcedecay spectrum(the lower
mass range) of the trypsin digest fragment (3 4)16 Da selected from the digestmixture of
the pool ofmodified2 peptides inA. The 16 Damass addition is located to the four C-terminal
residues PGFN, indicating a hydroxy-proline at position 25 instead of a proline residue. See E for
the product assignments. Other fragment ions of the y- and a-series are indicated.
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the presence of N-acetyl hexosamine (HexNac) (m/z of 204.0)
and HexNac-related ions (m/z of 186.0, 168, 144.3, 137.8, and
126.5). The ions at m/z of 186 and 168 may be explained as water
losses. The ion at 144 most likely arises from protonated HexNac
by a formal loss of acetic acid, i.e., loss of water and additional loss
of the amide-linked acetyl group. The ion at 126 would then
correspond to loss of acetyl and loss of two water molecules. The
same ions were detected in the low-mass regions of G2 and H2
(data not shown).
The spectrum of the modified 2 peptides digested with tryp-
sin also indicated that the site of the 16 Da modification on 2
peptides F2, G2, and H2 is at the C terminal of the peptides. This
can be deduced from the presence of an additional peak with a
mass corresponding to that of the disulphide-linked tryptic pep-
tides 3 and 4,16 Da (Fig. 3A, left). To further characterize this
fragment, we subjected it to post-source decay analysis (Fig. 3D),
which yielded y ions at m/z of 175 (y1), 272 (y2), 409 (y3), and
546 (y4). Cleavage at the disulphide bond yielded the fragment
ions atm/z of 809 and 743. The 16Damass incrementwas located
on the C-terminal fragment PGFN (atm/z of 435). No additional
sequence information was observed on the PGFN moiety.
Among these four amino acid residues, amodification of 16Da is
most likely located on the proline residue, because it corresponds
to the commonly occurring hydroxy-proline residue. Further-
more, during Edman sequencing, an extra peak in addition to
proline was also observed, which eluted in a position expected for
hydroxy-proline (data not shown).
In summary, the above sequencing and peptide mapping data
of the  peptide family members identified peptide E2 as
hydroxy-proline-containing 2 peptide (HyP-2 peptide), pep-
tide F as monoglycosylated 2 peptide, peptide F2 as monogly-
cosylated HyP-2 peptide, peptide G as diglycosylated 2 pep-
tide, peptide G2 as diglycosylated HyP-2 peptide, peptide H as
triglycosylated 2 peptide, peptide H2 as triglycosylated HyP-2
peptide, and peptide D2 tentatively as HyP-1 peptide.
Edman degradation of the molecule of 6455.5 Da in fraction
113 (Fig. 2) corresponding to molecule K in the VD1 spectrum
(Fig. 1) revealed the N-terminal sequence of the  peptide
(GSPYEPSLKDSFADSLTGKDQI. . . ). This suggests that peptide
K and the peptide have the same peptide backbone and differ by
a posttranslational modification of 80 Da, presumably the phos-
phorylation of a single amino acid residue. To confirm this as-
sumption, peptide K was digested with alkaline phosphatase,
which removed the phosphate group from the peptide, resulting
Figure 5. Peptide mapping of purified molecule I, PCR strategy, and cDNA encoding peptide I. A, Purification of the endo-lys-c digested peptides of molecule I by reverse-phase HPLC. Themain
UV absorbing peak indicated contained the digest fragment of 1451.2 Da, which was subjected to amino acid sequence analysis. The dashed line indicates the gradient of acetonitrile. Inset in A,
MALDImass spectrumof the endo-lys-c digest ofmolecule I before purification.B, Schematic representation of the sequence strategy to obtain the cDNA of the peptide I. Both 5 and 3RACE clones
were sequenced in both orientations. Scale bar, 500 nt. C, Northern blot analysis of visceral and parietal ganglia shows a single band of 1.8 kbwhen hybridized to a peptide I-specific random labeled
[- 32P]dATP probe. The transcript size markers (yeast ribosomal RNAs) 26S (3400 bases) and 18S (1800 bases) are indicated.D, Nucleotide sequence and deduced amino acid sequence of peptide
I cDNA. The number of nucleotides is indicated at the end of each line. Amino acid sequence number of peptide I starts at the predicted N-terminal residue (vertical arrow) and is indicated above the
sequence. The consensus for polyadenylation is shown in bold.
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in a reducedmass of peptide K by 80Da (Fig. 4A). Using software
to predict phosphorylation sites (Netphos 2.0; http://www.cbs.
dtu.dk/services/NetPhos/) (Blom et al., 1999), the  peptide se-
quence contains eight predicted phosphorylation sites (Fig. 4B).
To locate the site of phosphorylation, peptideKwas digestedwith
trypsin, and the tryptic fragments were detected by mass spec-
trometry. Figure 4C shows that the C-terminal tryptic peptide is
detected at a mass increment of 80 Da, suggesting that either the
Thr at position 50 (Netphos score of 0.623) or the Ser at position
53 (Netphos score of 0.992) (Fig. 4B) is phosphorylated, with the
latter being more likely.
Molecule I at m/z of 6020.2 in the single-cell spectrum of VD1
(Fig. 1A) was located in fraction 67 (m/z of 6019.1) of the HPLC
fractions (Fig. 2). Edman sequencing revealed the N-terminal
sequence of this peptide as GPIGAKKF, which is a unique se-
quence not present in the National Center for Biotechnology
Information (NCBI) database. To obtain internal sequence in-
formation, the purified molecule I was digested with endo-lys-c,
and the fragments were purified by a C18 column (Fig. 5A).
Amino acid sequence analysis of the main fragment at m/z of
1451.2 Da in fraction 36 yielded the sequence AYEDREFVPVPK,
which is also not present in the NCBI database. The obtained
amino acid sequences indicate that peptide I is a novel peptide.
These sequenceswere subsequently used to synthesize degenerate
oligonucleotides for a PCR experiment to characterize the neu-
ropeptide precursor dubbed the peptide I precursor.
Together, the peptide purification and characterization data
explained all of the major unidentified molecular ions from the
VD1 single-cell spectrum and revealed both novel peptide ex-
pression as well as extensive posttranslational modifications of
previously identified peptides.
Characterization of the novel peptide I precursor and cellular
localization of the transcript
To elucidate the structure of the precursor encoding peptide I, a
PCR strategy was used on cDNA of a single neuron, i.e., RPD2,
which also contains peptide I (Jimenez et al., 1998). Using tripli-
cate reactions of 5 RACE and 3 RACE, a compiled peptide I
encoding cDNA of 633 nt was obtained (Fig. 5B,D). The longest
open reading frame of 222 nt is flanked by a 113 nt 5 leader and
a 298 nt 3 untranslated region. The proposed initiation codon
Met-1 is preceded by an upstream in-frame stop codon. Taking
into account that Northern blot analysis detected a transcript of
1.8 kb (Fig. 5C), we conclude that the peptide I encoding cDNA
of 633 nt represents a cDNA that is not full length. Nevertheless,
only 5 and 3 untranslated sequences are missing because the
cDNA clone comprises the complete open-reading frame. The
deduced amino acid sequence of the peptide I cDNA contains a
hydrophobic leader sequence that is predicted to be cleaved after
Ala-20 (von Heijne, 1983) and a single peptide domain of 53
amino acids. The predicted protonated mass of the peptide I is
6027Da,whereas themeasured protonatedmass is 6019.1/6020.2
Da (mass accuracy of0.05%). Therefore,most likely the six Cys
residues are connected via three disulphide bridges, yielding a
protonated molecular weight of 6021 Da (Table 1).
The cellular localization of mRNA of peptide I was studied in
sections of the visceral and right parietal ganglia of L. stagnalis by
in situ hybridization (Fig. 6A,B, respectively). VD1 and RPD2
neurons were identified on alternating sections by immunocyto-
chemistry using an anti-1 peptide antibody (Fig. 6C,D, respec-
tively). The transcripts of peptide I are present in both neurons,
confirming the peptide profiles obtained byMALDI-TOF-MS of
single VD1 and RPD2 (Jimenez et al., 1998).
Functional connectivity of VD1 to the heart
Previous morphological (Kerkhoven et al., 1991), physiological,
pharmacological (Bogerd et al., 1994), and peptide chemical
(Jimenez et al., 1998) studies indicated that VD1 and RPD2 may
modulate heart beat via the use of its cardioactive peptide trans-
mitters. These in vivo studies do not, however, provide unequiv-
ocal evidence that these effects were indeed mediated directly.
To further investigate the role of VD1 inmodulating heart cell
activity, we cocultured VD1, isolated from the brain, with enzy-
matically dissociated auricle and ventricle cells. First, we con-
firmed that the dissociated auricle and ventricle muscle fibers
were functionally viable. Specifically, muscle contractions were
induced by applying 2 peptide exogenously. An example of the
effect of2 peptide on the ventriclemembrane potential is shown
in Figure 7A (n 	 12). Next, the neuron VD1 was isolated and
coculturedwith the dissociatedmuscle fibers. After 24 h of cocul-
ture, simultaneous intracellular recordings clearly show the pres-
ence of synaptic connections between VD1 and the heart muscle
fibers (Fig. 7B–F) (n 	 17). Spiking activity in VD1 induced by
depolarizing current resulted in 1:1 excitatory junction potential
(EJP) in the muscle cells (Fig. 7), indicating the presence of a
chemical synapse. These synapses were clearly chemical because
hyperpolarizing current pulses in VD1 (Fig. 7B) were not regis-
tered in the muscle fiber and the synaptic transmission was com-
pletely blocked by zero Ca2 saline (data not shown). Moreover,
in the in vitro coculture situation, the effects of VD1 on isolated
heart muscle cells were voltage dependent. As the resting mem-
brane potential of the postsynaptic muscle was brought closer to
its restingmembrane, theVD1-inducedEJPs in the target became
smaller, albeit generating spikes in the muscle fiber (Fig. 7D–F)
(n	 7). To test for the specificity of synapse formation, the heart
muscle was paired with RPeD1 (does not innervate heart), and
synapses were tested electrophysiologically. We found that, de-
spite extensive physical contacts, RPeD1 failed to establish syn-
apse with the ventricular muscle fiber (Fig. 7G) (n	 5).
Figure 6. Localization of the peptide I transcript. A–D, Cellular localization of the peptide I
transcript by in situhybridization in VD1 (A) and RPD2 (B) and identification of VD1 andRPD2by
immunostaining (C,D, respectively) with an anti- peptide antibody on parallel sections of the
brain. Arrows indicate VD1, and arrowheads indicate RPD2.
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Convergence of VD1 peptides onto the same calcium channel
in dissociated heart muscle cells
To unequivocally establish the presence of receptors for the dif-
ferent colocalized VD1 and RPD2 peptides on muscle cells of the
heart and to study their functional role (including the glycosy-
lated forms of the 2 peptide), we measured the electrophysio-
logical effects of the differentially modified 2 peptides, SCPb,
peptide I, and the phosphorylated  peptide on dissociated heart
muscle cells. Under whole-cell voltage-clamp control conditions,
muscle cells from the auricle responded to step depolarizations
with variable time- and voltage-dependent outward currents.
Ventricle muscle cells displayed reproducible responses to step
depolarizations. Therefore, the effects of the VD1/RPD2 peptides
were compared ondissociated ventricle cells. All VD1/RPD2pep-
tides tested causedmost prominent effects
on the inward currents (Figs. 8, 9). Using
saline containing barium ions, we ob-
served both a low-voltage-activated
(LVA) and a high-voltage-activated
(HVA) current in the ventricle cells (Fig.
8A,B). The LVA current was rapidly inac-
tivating and insensitive to dihydropyri-
dines and appeared not to be modulated
by the VD1/RPD2 peptides (Fig. 8B). The
HVA current was suppressed by the dihy-
dropyridine nicardipine (81 12% block
by 1 M; means SEM; n	 4) (data not
shown). Therefore, the HVA current can
be classified as a typical L-current, in
agreement with a previous study in which
this current was analyzed in more detail
(Yeoman et al., 1999).
The2 peptide caused a consistent and
dose-dependent increase in the amplitude
of the L-type current (Fig. 8). We did not
observe any changes in kinetic properties
or voltage dependence. The dose depen-
dence was determined for the range of
109 to 106 M (Fig. 8C). Between 107
and 106 M, the dose–effect curve was
very steep, with a maximal effect of the
barium current observed at 5  106 M
(Fig. 8C). The dose–response curve can be
described by a four-parametric Hill func-
tion (r	 0.9908), and the effect of concen-
tration is significant (one-way ANOVA,
p	 0.0037). Because saturation of the re-
sponse did not yet occur within this con-
centration range, the EC50 cannot be de-
terminedwith certainty but is estimated to
be2 107 M. Responses to higher con-
centration of 2 peptide could not be re-
corded because of the contractions of the
muscle fibers. Next, we investigated
whether the posttranslationally modified
2 peptidesmimicked the effect of the un-
modified 2 peptide. Like unmodified 2
peptide, the different modified 2 pep-
tides (HyP-2 peptide E2, monoglycosy-
lated HyP-2 peptide F2, diglycosylated
HyP-2 peptide G2, and triglycosylated
HyP-2peptideH2)all increased theampli-
tudeof theHVA-bariumcurrentwithout al-
tering the kinetics or voltage dependence. An example of the re-
sponse of the monoglycosylated HyP-2 peptide F2 is shown in
Figure 9A. Interestingly, the modified 2 peptides yielded larger re-
sponses than the 2 peptide itself (Student’s t test, p
 0.05). Com-
paring the effect of the same concentration (2.5 108 M) demon-
strates that the differentially glycosylated HyP-2 peptides F2, G2,
andH2areequipotent andapproximately twofoldmorepotent than
HyP-2 peptide E2 (Student’s t test, p 
 0.05), which in turn is
approximately twofold more potent than unmodified 2 peptide
(Student’s t test, p
 0.05) (Fig. 8D) (n	 5 for each peptide).
Testing the effect of SCPb on the isolated barium currents
showed a striking effect of SCPb on the HVA-barium current (Fig.
9B). The threshold concentration for this effectwas 1M(n	 4). At
10MSCPb, the increase of this current amounted to 300% (n	 3)
Figure7. Synaptic transmissionbetweenVD1andheartmuscle cells in vitro.A, Effect of synthetic2peptide (108M) applied
by pressure application on a ventricle muscle fiber (VMF). B–F, Chemical synapses between VD1 and auricle muscle fiber (AMF)
and ventricle muscle fiber reform in cell culture. Simultaneous intracellular recordings from VD1 and auricle muscle fiber did not
reveal electrical coupling between the cells. However, depolarizing current injected in VD1 (at filled arrow) triggered spikes in this
cell, which induced 1:1 EJPs in the auricle muscle fiber. Open arrow represents hyperpolarizing current injection to determine the
incidence of electrical coupling between the cells. C, Similarly, induced action potentials in VD1 induced 1:1 EJPs in the ventricle
muscle fiber.D–F, Voltagedependenceof themuscle cell response toVD1 stimulation. To showthat the synapsebetweenVD1and
the auricle muscle fiber is indeed excitatory, the postsynaptic potentials were tested at various different membrane potentials
(80 to60mV). Raising themembrane potential closer to its threshold (60mV; F ) generated action potential in themuscle
fiber.G, A heart muscle fiber coculturedwith a nonsynaptic partner, RPeD1, did not develop synapses because the induced action
potentials in RPeD1 failed to elicit any response in the ventricle muscle fiber despite physical contacts between the cells.
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(Fig. 9B). Finally, purified peptide I and purified phosphorylated 
peptide (peptide K) were applied to dissociated ventricle cells at a
concentrationof5107M.Peptide I clearly enhanced theHVA-
barium currents of ventricle cells by100% (n	 5). An example of
the current traces and I–V relationships is shown in Figure 9C.
Therefore, we renamed peptide I to Lymnaea calcium current acti-
vating peptide (LyCCAP). The phosphorylated  peptide did not
have anyeffect on theHVA-bariumcurrentsof ventricle cells (n	5;
data not shown). The unphosphorylated  peptide (peptide J) and
the C-terminal peptide of the SCP precursor (peptide L) were not
tested because they could not be purified in large enough quantities
for physiological experiments.
Discussion
Peptide diversity in VD1 and RPD2
In this study, we structurally and functionally characterized hith-
erto unidentified peptides in VD1 and RPD2 that were initially
discovered by direct mass spectrometric peptide profiling of sin-
gle neurons (Jimenez et al., 1994, 1998; and this study, Fig. 1). A
summary of the precursors and proposed processing pathways
of the peptides is shown in supplemental Figure 1 (available at
www.jneurosci.org as supplemental material).
Diversity generated by different genes, alternative splicing,
and processing of precursors
VD1 and RPD2 express in total three genes that encode four
peptide precursors with distinct structural organization. The
novel LyCCAP precursor expressed in both neurons contains
only a single functional peptide domain, with no homology to
other sequences in the NCBI database. The processing of LyC-
CAP and SCP precursors to their respective peptides conform to
the consensus sequences for proteolytic processing encoded in
their precursors. Thepeptide pre-mRNA is alternatively spliced
to generate two mRNAs, giving rise to the 1 and 2 peptide
precursors (Bogerd et al., 1993). Not all predicted dibasic cleav-
age sites (Lys-Arg or Arg-Arg) (Steiner et al., 1992) in the  pep-
tide precursors are cleaved by the prohormone convertases. Be-
cause we have detected a peptide at m/z of 1160.0 with the
primary sequence DRRLNGDTVN, the double Arg residues at
positions 38 and 39 are not used as a cleavage site.
Peptide diversity generated by posttranslational modification
We characterized multiple posttranslational modifications of the 
and  peptides derived from the  peptide precursors. The 1 and
2 peptides are highly similar and differ only in the N terminal, in
which theTyr-Glu residues at positions 3 and4 in1 are replacedby
Val-Thr-Thr-Thr-Arg-Ile-Gly-Thr-Gly in2.Using tryptic peptide
mapping and tandemMSanalysis, we demonstrated the presence of
threedifferentiallyglycosylated2peptides,most likelydifferentially
modified on the three Thr residues in the N terminal. Absence of
these residues in the 1 peptide explains the lack of glycosylation of
1.TandemMSofmodified2peptidesdemonstrated thepresence
of HexNac, which is commonly found in O-linked sugars attached
to Ser and Thr residues. The carbohydrate of 379 Damay consist of
HexNac–hexuronic acid, because this is theonly structurepredicted
by the GlycoMod tool. Glycosylation of protein hormones has been
implicated in protein folding, stability (Baudys et al., 1995; Kihlberg
et al., 1995; Haneda et al., 2001), intracellular transport, enhanced
receptor binding, and biological potency (Flack et al., 1994; Nissen,
1994; Furuhashi et al., 1995).However, few reports exist on thepres-
enceandfunctionsofnaturallyoccurringglycosylatedpeptides (Ivell
et al., 1981; Nakakura et al., 1992). Therefore, in addition to their
increased signalingproperties, thedifferentially glycosylated2pep-
tides may have several other features than the unmodified 2
peptide.
Besides differential glycosylation, the Pro residue 25 of each
2 peptide is differentially modified into a HyP variant. Hy-
droxylation is a common posttranslational modification of Pro
residues that occur in collagens (McCormack et al., 1994; Gaill et
al., 1995). Because the HyP residues are especially important for
noncovalent interactions between proteins, it may be speculated
that the higher potency of the HyP-containing 2 peptide is
caused by increased receptor binding.
Edman degradation in conjunction with phosphatase treatment
and trypticpeptidemassmappingdemonstrated that themajorityof
Figure 8. Voltage-dependent barium currents in Lymnaea ventricular cells and modulation
by the2peptide family.A, I–V relationships of currents recorded in ventricle cell. Left, Control;
right, in the presence of 100 nM2 peptide.B, Voltage step protocolswere applied froma80
mV holding potential to40 and10mV. The current traces of a representative ventricle cell
show the LVA and HVA current in the control condition and in the presence of 2 peptide. C,
Dose–response curve of the2peptide. Effects of2peptidewere tested in the range of 109
to 106 M. Each concentrationwas tested on different cells: n	 4 for 109 M; n	 5 for 108
M; n	 8 for 107 M; n	 6 for 2 107 M; n	 5 for 5 107 M; and n	 5 for 106 M. The
data are described by a four-parameter Hill function (r	 0.9908). D, Quantitative comparison
of the effects of the modified 2 peptides, HyP-2 (E2), monoglycosylated HyP-2 peptide
(F2), diglycosylated HyP-2 peptide (G2), and triglycosylated HyP-2 peptide (H2), on the
ventricle cell HVA-barium current, each applied at 2.5 108 M; n	 5 for each peptide. Error
bars indicate SEM values. Peptides were tested on different cells. The enhancement of the
barium current by the glycosylated-hydroxy-proline 2 peptide variants was significantly
larger than the effect of the hydroxy-proline variant of2 peptide that in turnwas significantly
larger than the effect of unmodified2 peptide. OH, Hydroxy-proline. **p
 0.05, t test.
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peptide is phosphorylated. In theC-terminal part of thepeptide,
the casein kinase consensus site (i.e., -Ser/Thr-X-X-Glu/Asp-) at the
Ser residue at position 53 is most likely phosphorylated (NetPhos
score of 0.992). Casein kinases are present at the luminal side of the
Golgi apparatus (Vegh and Varro, 1994), and, therefore, they may
phosphorylate the  peptide during passage through the Golgi
apparatus.
VD1modulates heartbeat via a direct
neuromuscular connection
In vitro experiments in this study support the idea that VD1modu-
lates heartbeat via the use of its peptides. Coculture experiments of
VD1 and RPeD1 and dissociated heart auricle and ventricle cells
show that excitatory synapses are selectively formed in vitro between
VD1andheart cells. The successful synapse formationbetweenVD1
and heartmuscle cells is in line with previous immunocytochemical
findings (Kerkhoven et al., 1991) that showed the presence of nu-
merous 1 peptide-positive varicosities terminating on auricle tra-
becularmuscle fibers, which are reminiscent of synapses.Moreover,
VD1 and RPD2 peptides derived from all prohormones can be de-
tected inbiopsiesofheart tissueusingmass spectrometry (Jimenezet
al., 1998). However, VD1 is not the only neuron that sends projec-
tions to the heart. Several peptidergic and nonpeptidergic heartmo-
tor neurons have been described in the past (Buckett et al., 1990a,b),
indicating a rich innervation of the myogenic heart of Lymnaea.
Differentially modified 2 peptides, SCPb, and LyCCAP
converge onto calcium channels in dissociated heart
ventricle cells
We compared the effects of selected peptides of VD1 and RPD2
on membrane currents of heart ventricle muscle fibers, because
they displayedmore reproducible voltage-activated currents than
the auricle fibers. The voltage-clamp recordings showed that a
dihydropyridine-sensitive HVA current belonging to the L-type
family is modulated by all tested variant
2 peptides, but significant quantitative
differences were observed between them,
with the posttranslationally modified
forms being more potent. The SCPb pep-
tide modulated the same HVA L-type cal-
cium current as the 2 peptides, but the
threshold of the response was higher than
that for 2 and the modulatory effect re-
versed very slowly. Interestingly, the novel
peptide LyCCAP also activated this cur-
rent, with kinetics similar to the 2 pep-
tides. Together, our voltage-clamp exper-
iments show that seven peptides,
representing three peptide families, ex-
hibit convergent activation of a HVA
L-type calcium current. Interestingly, this
current is also modulated by FMRFamide
(Brezden et al., 1999), from heart motor
neurons (Buckett et al., 1990). Recently,
the possible role of this current was inves-
tigated in detail in heart ventricle cells of
Lymnaea by Yeoman and Benjamin
(1999). They showed that the L-type cur-
rent is important for pacemaking in gen-
erating action potentials and in providing
calcium for contraction-excitation cou-
pling. Therefore, modulation of the
L-type current by VD1 peptides may alter
the myogenic beating rate of the heart.
Convergent and divergent neuromodulation
The frequent occurrence of colocalized neurotransmitters sug-
gests that the combination of transmitters released by a neuron
attributes specificity to its actions (Kupfermann, 1991; Brezina
and Weiss, 1997). The results reported here are interesting and
perhaps surprising for several reasons: first, because VD1 and
RPD2 cosynthesize such a large array of chemically diverse pep-
tides; and second, becausemost of these peptides converge onto a
single type of calcium channel to modulate a single type of Ca
current. To the best of our knowledge, this study is the first to
demonstrate that single neurons exhibit such a complex pattern
of peptide gene expression, precursor processing, and modifica-
tions. The present results indicate that neuropeptides derived
from three different genes ( peptides, SCPs, and LyCCAP) can
exhibit activation of the same effector protein, the L-type HVA
calcium channel. This remarkable degree of convergence in neu-
romodulation was also observed in the crustacean somatogastric
ganglion (Swensen and Marder, 2000; Nusbaum et al., 2001).
Convergence might prevent overmodulation by multiple modu-
latory inputs.
In addition to their convergent effects, it is feasible that 
peptides and SCPs (and possibly LyCCAP) may also exert diver-
gent effects. Based on the complexity of the whole auricle re-
sponse and the differential effects of 2 peptide and SCPb appli-
cation (Jimenez et al., 1998), it is likely that these peptides
influence more than one channel type in Lymnaea heart muscle
cells. This notion is consistent with the observation that the syn-
aptic effects of VD1 in the coculture were evident even at varying
hyperpolarizing potentials, suggesting the involvement of other
ion channels, in addition to the HVA calcium channel. The po-
tential discrepancy between sharp electrode and patch-clamp re-
cordings may also be attributable to differential sensitivities of
Figure 9. Selective increase of the HVA-barium current in ventricle cells by monoglycosylated HyP-2 peptide F2, SCPb, and
peptide I/LyCCAP. A–C, Family of current traces at40 to20mV (10mV steps) in the absence (left) and presence (middle) of
monoglycosylatedHyP-2 peptide F2 (A), SCPb (B), and peptide I/LyCCAP (C). Voltage step protocolswere applied as indicated in
the right panel. Currents of representative ventricle cells are shown. Application of each peptide caused a strong increase in the
HVA current.
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synaptic (coculture) and extrasynaptic (single cells) peptidergic
receptors. Regarding the molecule mediating VD1-induced EJPs
in heart muscle fibers, we believe this be a (combination of) pep-
tide(s) because there is no evidence for the presence of small
molecule transmitters in either VD1 somata or its axonal
branches (Boer et al., 1979;Winlow et al., 1998; Feng et al., 2000).
Together, it might be speculated that, through a process of com-
binatorial convergence and divergence (Brezina and Weiss,
1997), flexibility in neuronal output can be generated.
The full functional implications of the expression of such a
variety of neuropeptides in VD1must await detailedmorpholog-
ical and physiological studies. For example, it will be interesting
to investigate whether the three different classes of cardioactive
peptides in VD1 are colocalized in the same granules and thus
obligatory coreleased or whether they are packaged in distinct
granule types. In the latter case, differential release depending on
the firing pattern may dynamically vary the ratio of the released
peptides. Finally, the complexity of the peptide profiles in VD1
may be a general feature of widely acting modulatory neurons
that, through extensive projection patterns, modulate a large
number of targets. Possibly, in these modulatory neurons, a large
array of different types of peptides is needed for (fine tuning of)
the coordination of diverse target cells.
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